Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Kabra Drugs Limited
Kabra Drugs Limited has been active since 1989, providing more than 37 years of industry experience. Corporate ID: L02423MP1989PLC005438, registered with number 5438. The firm is categorized as company limited by shares. The declared authorized capital is ₹20.00 crore. Paid-up capital currently stands at ₹10.08 crore.
The firm focuses on forestry, logging and related service activities. The company’s registration location is Gwalior. The company is incorporated with the address 208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011. The firm continues to be in active status. Kabra Drugs Limited can be contacted at kabradrugs@gmail.com. At the helm are Bangalore Venkatakrishnappa Ananth Kumar (CFO).
Company Overview
- CIN
- Date of Incorporation
- 22/08/1989
- Company Status
- Active
- RoC
- Gwalior
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹20,00,00,000.00
- Paid up Capital
- ₹10,07,91,000.00
- Activity
- FORESTRY, LOGGING AND RELATED SERVICE ACTIVITIES
- kabradrugs@gmail.com
- PAN
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8323K01016 | KABRA DRUGS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | KABRA DRUGS/SH VTG | ESVUFN |
| INE323K01017 | KABRA DRUGS LIMITED EQ | - | 12/10/2026 | KABRA DRUGS/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹83.54L | ₹4.39L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross PPE | ₹83.54L | ₹5.12L | ₹16.63L | ₹16.63L | ₹0.00L |
| Inventory | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹56.91L | ₹43.74L | ₹170.85L | ₹138.19L | ₹0.00L |
| Common Stock | ₹2,370.79L | ₹2,370.79L | ₹438.86L | ₹438.86L | ₹0.00L |
| Current Debt | ₹42.91L | ₹43.74L | ₹170.85L | ₹138.19L | ₹0.00L |
| Share Issued | ₹237.08L | ₹237.08L | ₹43.89L | ₹43.89L | ₹0.00L |
| Total Assets | ₹8,627.06L | ₹2,522.90L | ₹457.15L | ₹70.36L | ₹0.00L |
| Capital Stock | ₹2,370.79L | ₹2,370.79L | ₹438.86L | ₹438.86L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹8,392.34L | ₹2,516.19L | ₹454.84L | ₹68.04L | ₹0.00L |
| Working Capital | ₹2,738.36L | ₹2,458.80L | ₹105.97L | -₹75.42L | ₹0.00L |
| Invested Capital | ₹3,004.36L | ₹2,509.21L | ₹279.14L | ₹65.09L | ₹0.00L |
| Other Properties | ₹83.54L | ₹0.61L | ₹0.00L | ₹0.00L | ₹0.00L |
| Common Stock Equity | ₹2,961.45L | ₹2,465.47L | ₹108.29L | -₹73.10L | ₹0.00L |
| Net Tangible Assets | ₹2,960.80L | ₹2,465.47L | ₹108.29L | -₹73.10L | ₹0.00L |
| Tangible Book Value | ₹2,960.80L | ₹2,465.47L | ₹108.29L | -₹73.10L | ₹0.00L |
| Current Liabilities | ₹5,653.98L | ₹57.39L | ₹348.87L | ₹143.46L | ₹0.00L |
| Stockholders Equity | ₹2,961.45L | ₹2,465.47L | ₹108.29L | -₹73.10L | ₹0.00L |
| Other Equity Interest | ₹590.66L | ₹94.68L | ₹255.00L | ₹0.00L | -₹478.17L |
| Total Capitalization | ₹2,961.45L | ₹2,465.47L | ₹108.29L | -₹73.10L | ₹0.00L |
| Ordinary Shares Number | ₹237.08L | ₹237.08L | ₹43.89L | ₹43.89L | ₹0.00L |
| Other Intangible Assets | ₹0.65L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | ₹2.31L | ₹2.32L | ₹2.32L | ₹0.00L | ₹2.32L |
| Total Non Current Assets | ₹234.71L | ₹6.71L | ₹2.32L | ₹2.32L | ₹0.00L |
| Cash And Cash Equivalents | ₹1,058.23L | ₹2,129.92L | ₹267.10L | ₹0.29L | ₹0.00L |
| Other Short Term Investments | ₹4.36L | ₹4.36L | ₹375.44L | ₹0.00L | ₹0.09L |
| Other Non Current Liabilities | -₹0.01L | -₹0.01L | -₹0.01L | ₹0.00L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹0.65L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹2,961.45L | ₹2,465.47L | ₹108.29L | -₹73.10L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹5,665.61L | ₹57.43L | ₹348.86L | ₹143.46L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹45.87L | ₹43.74L | ₹170.85L | ₹138.19L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹11.04L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹1,062.59L | ₹2,129.92L | ₹267.10L | ₹0.29L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹11.63L | ₹0.04L | -₹0.01L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Free Cash Flow | -₹1,034.25L | -₹475.81L | -₹20.85L | -₹35.44L |
| Changes In Cash | -₹1,071.71L | ₹1,862.82L | ₹266.81L | ₹0.17L |
| End Cash Position | ₹1,058.23L | ₹2,129.93L | ₹267.10L | ₹0.29L |
| Financing Cash Flow | ₹11.50L | ₹2,338.63L | ₹287.66L | ₹35.61L |
| Investing Cash Flow | -₹135.78L | -₹5.13L | ₹0.00L | ₹0.00L |
| Operating Cash Flow | -₹947.43L | -₹470.68L | -₹20.85L | -₹35.44L |
| Capital Expenditure | -₹86.82L | -₹5.13L | ₹0.00L | ₹0.00L |
| Beginning Cash Position | ₹2,129.93L | ₹267.10L | ₹0.29L | ₹0.13L |
| Issuance Of Capital Stock | ₹0.00L | ₹2,465.74L | ₹255.00L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | ₹0.01L | ₹0.01L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹575.07L | -₹108.51L | -₹73.61L | -₹33.79L | ₹0.00L |
| EBITDA | ₹582.18L | -₹107.78L | -₹73.61L | -₹33.79L | ₹0.00L |
| Basic EPS | ₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Net Income | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Diluted EPS | ₹0.00L | -₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Gross Profit | ₹907.60L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Pretax Income | ₹572.07L | -₹108.51L | -₹73.61L | -₹33.79L | ₹0.00L |
| Tax Provision | ₹76.09L | ₹0.05L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹9,274.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cost Of Revenue | ₹8,366.40L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Expenses | ₹8,748.20L | ₹172.52L | ₹73.56L | ₹34.40L | ₹0.00L |
| Interest Expense | ₹3.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Income | ₹525.80L | -₹172.52L | -₹73.56L | -₹34.40L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹582.18L | -₹107.78L | -₹73.61L | -₹33.79L | ₹0.00L |
| Normalized Income | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Operating Expense | ₹381.80L | ₹172.52L | ₹73.56L | ₹34.40L | ₹0.00L |
| Operating Revenue | ₹9,274.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Interest Income | -₹3.00L | ₹0.00L | -₹0.05L | ₹0.61L | ₹0.00L |
| Total Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹237.31L | ₹237.08L | ₹43.89L | ₹43.89L | ₹0.00L |
| Diluted Average Shares | ₹237.31L | ₹237.08L | ₹43.89L | ₹43.89L | ₹0.00L |
| Other Operating Expenses | ₹228.10L | ₹102.56L | ₹25.56L | ₹3.36L | ₹0.00L |
| Reconciled Depreciation | ₹3.70L | ₹0.73L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹8,366.40L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹3.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Common Stockholders | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Net Income Continuous Operations | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹3.00L | ₹0.00L | -₹0.05L | ₹0.61L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹495.98L | -₹108.56L | -₹73.61L | -₹33.79L | ₹0.00L |
Company Performance (FY26)
₹92.7 Cr₹69.6 Cr₹46.4 Cr₹23.2 Cr₹0
FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 29/01/2020 | Bangalore Venkatakrishnappa Ananth Kumar | 08644948 | Whole-time director | View other directorships |
| 29/01/2020 | Bangalore Venkatakrishnappa Ananth Kumar | *****0551M | CFO | |
| 19/02/2020 | Ananthkumar Shilpa | 08677992 | Director | View other directorships |
| 09/06/2022 | Kuniamuthur Nanjappan Anand | 03230186 | Director | View other directorships |
| 14/07/2022 | Anand Anitha | 02040505 | Director | View other directorships |
| 14/07/2022 | Monika Nishant Gattani | *****0301N | Company Secretary | |
| 14/08/2024 | Nanjappan Aravind | 01895602 | Additional Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 7
- Bangalore Venkatakrishnappa Ananth KumarWhole-time director
- Anand AnithaDirector
- Kuniamuthur Nanjappan AnandDirector
- Ananthkumar ShilpaDirector
- Nanjappan AravindAdditional Director
- Monika Nishant GattaniCompany Secretary
- Bangalore Venkatakrishnappa Ananth KumarCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 29/11/2024 | Form MGT-7-29112024 | - |
| 12/11/2024 | Form AOC-4(XBRL)-29102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Beryl Drugs Limited | L02423MP1993PLC007840 | 133 Kanchan Bagh, Indore, Indore, Madhya Pradesh, India, 452001 |
| Bonanza Biotech Limited | L02423MP1981PLC001779 | 203, Apolo Tower, 2, M.g. Road, Indore, Madhya Pradesh, India, 000000 |
Address
208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011
Frequently Asked Questions
What is the incorporation date of Kabra Drugs Limited?
The incorporation date of Kabra Drugs Limited is 22/08/1989.
What is the authorized share capital and paid-up capital of Kabra Drugs Limited?
The authorized share capital of Kabra Drugs Limited is ₹20,00,00,000.00. The paid-up capital is ₹10,07,91,000.00.
Who are the current board members & directors of Kabra Drugs Limited?
The current board member of Kabra Drugs Limited are:
- Ananthkumar Shilpa
- Kuniamuthur Nanjappan Anand
- Bangalore Venkatakrishnappa Ananth Kumar
- Anand Anitha
- Nanjappan Aravind
What is the registered address of Kabra Drugs Limited?
The registered address of Kabra Drugs Limited is 208 Swadesh Bhavan, 2 Press Complex, Ab Road, Indore R.s.s.nagar, Indore, Indore, Madhya Pradesh, India, 452011.
What is the Corporate Identification Number of Kabra Drugs Limited?
The Corporate Identification Number of Kabra Drugs Limited is L02423MP1989PLC005438.